Compare TME & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TME | MEDP |
|---|---|---|
| Founded | N/A | 1992 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2B | 16.6B |
| IPO Year | 2018 | 2016 |
| Metric | TME | MEDP |
|---|---|---|
| Price | $8.28 | $591.35 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 12 |
| Target Price | $19.44 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 10.7M | 177.6K |
| Earning Date | 05-12-2026 | 04-22-2026 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | N/A | ★ 8.53 |
| Revenue | N/A | N/A |
| Revenue This Year | $10.73 | $13.19 |
| Revenue Next Year | $10.19 | $7.75 |
| P/E Ratio | ★ $15.69 | $68.84 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.94 | $373.00 |
| 52 Week High | $26.70 | $677.90 |
| Indicator | TME | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 37.52 | 48.88 |
| Support Level | $7.94 | $566.12 |
| Resistance Level | $9.92 | $628.29 |
| Average True Range (ATR) | 0.24 | 16.97 |
| MACD | -0.06 | -5.08 |
| Stochastic Oscillator | 14.36 | 27.54 |
Tencent Music is the largest online music streaming platform in China, established in 2016 through the merger of QQ Music, Kuwo Music, and Kugou Music. Tencent, its largest shareholder, holds over 50% of the shares and more than 90% of the voting rights. Beyond streaming services, Tencent Music generates revenue through a diverse range of offerings, including podcasts, livestreaming, concerts, and karaoke.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.